Sobi On The Look-Out For Licensing, M&A Opportunities
Executive Summary
Swedish Orphan Biovitrum AB may be in a launch phase with first sales of its long-acting hemophilia products in Europe, but the company is already looking ahead to use its growing commercial capabilities for other products.